CN Creative
Manchester, Manchester, United Kingdom
About CN Creative
Headquartered in the Bioscience Incubator at Manchester University in the UK, CN Creative provides innovative and sustainable solutions to global problems arising from smoking and smoking-related illnesses. It has developed a distinctive portfolio of products and services focused on smoking cessation and harm reduction, including user-friendly nicotine delivery systems and patient-focused smoking cessation and support services. CNC's diverse products include QuitDirect, an NHS-accredited supplier of comprehensive smoking cessation services, the Intellicig® electronic cigarette, ECOpure proprietary high purity nicotine preparations and NRT Direct, which provides traditional nicotine replacement therapy products and patient support services to publicly and privately sponsored smoking cessation programmes. CNC's Nicadex(TM) electronic inhaler nicotine replacement therapy product is in clinical development for use as part of medically supervised smoking cessation programmes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $3.1M
- Funding stage: M&A
- Last round: Series A (Jan 2012)
- Website: cncbio.co.uk
- Phone: +44 84 5544 1651
Industries & Categories
Biotechnology, Electronics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/cn-creative-2586762 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.